logo
  • Pipeline
    • Research Pipeline
    • Paltusotine
    • CRN04777, Oral SST5 Agonist
    • CRN04894, Oral ACTH Antagonist
  • Patients
    • Clinical Trials
    • Patient Videos
      • Clinical Trials
      • Acromegaly in a Pandemic
      • Acromegaly Symptoms
      • Acromegaly Diagnosis
      • Acromegaly Advocate
      • Acromegaly Support
  • Professionals
    • Acromegaly
    • Congenital Hyperinsulinism
    • Paltusotine (CRN00808)
  • Investors
    • Events
    • Press Releases
    • Presentations
    • Investor Resources
  • About Us
  • Careers
    • Culture
      • Employee Spotlight
      • Having Fun
      • Community
        • Rare Disease Awareness Day
    • Job Listings
    • Benefits
  • Contact
    • Contact Us
    • Partnering
https://crinetics.com/wp-content/uploads/2020/07/808-Rotation-D3.mp4

Scientist, Chemistry

Subscribe

The Better Bulletin is our periodic newsletter focused on endocrine disease. Subscribe to stay on top of our programs, pipeline, research, and more as we develop Better therapies for Better lives.

Add Me
crinetics logo full uai
  • Pipeline
  • Patients
  • Professionals
  • Press
  • Financials
  • Presentation
  • Events
  • Contact
  • Partnering
  • Careers
  • Culture
  • Job Listings
  • About
  • Terms
  • Privacy
  • Crinetics Facebook
  • Crinetics Twitter
  • Crinetics LinkedIn

(858) 450-6464 · 10222 Barnes Canyon Road, Building 2, San Diego, CA 92121
Crinetics Pharmaceuticals, Inc. © 2021 All rights reserved

crinetics logo full uai
  • Pipeline
  • Patients
  • Professionals
  • Financials
  • Presentation
  • Press
  • Events
  • Careers
  • Culture
  • Job Listings
  • About
  • Contact
  • Partnering
  • Privacy
  • Terms
  • Pipeline
  • Patients
  • Professionals
  • Presentation
  • Partnering
  • Financials
  • Press
  • About
  • Contact
  • Careers
  • Privacy
  • Terms
  • Crinetics Facebook
  • Crinetics Twitter
  • Crinetics LinkedIn

(858) 450-6464

10222 Barnes Canyon Road, Building 2,
San Diego, CA 92121

Crinetics Pharmaceuticals, Inc.
© 2021 All rights reserved